Why life-saving drugs often carry a massive, unavoidable price premium
In short: High pharmaceutical costs are driven by low elasticity of demand. This video explores how specific psychological and economic factors allow companies to set monopoly markups on essential medicine, making patients less sensitive to price changes.
The video highlights two primary drivers that diminish price sensitivity in the pharmaceutical market. The first is the 'you can't take it with you' effect, where individuals facing serious medical conditions prioritize life-saving treatment regardless of cost. The second is the 'other people's money' effect, which occurs when third parties cover the expense, further insulating the consumer from the actual price of the drugs.
These conditions create a market environment where demand remains inelastic, granting manufacturers the leverage to implement significant markups. Understanding these mechanisms explains why price competition often fails to function in the healthcare sector as it does in other industries.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: The Monopoly Markup
To cite this card, link to https://intellectplus.co.uk/app/wealth-the-monopoly-markup.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?